Welcome to LookChem.com Sign In|Join Free

CAS

  • or

1103500-32-8

Post Buying Request

1103500-32-8 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

1103500-32-8 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 1103500-32-8 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,1,0,3,5,0 and 0 respectively; the second part has 2 digits, 3 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 1103500-32:
(9*1)+(8*1)+(7*0)+(6*3)+(5*5)+(4*0)+(3*0)+(2*3)+(1*2)=68
68 % 10 = 8
So 1103500-32-8 is a valid CAS Registry Number.

1103500-32-8Downstream Products

1103500-32-8Relevant articles and documents

PPARs-FXR multi-target micromolecular agonist as well as preparation method and application thereof

-

Paragraph 0092; 0095; 0097; 0143-0148, (2021/05/22)

The invention discloses a PPARs-FXR multi-target micromolecule agonist and a preparation method and application thereof, the structure is shown in a general formula I, and the definition of each substituent group is shown in the description and claims. Th

Isoxazole FXR receptor agonist as well as preparation method and medical application thereof

-

, (2021/07/14)

The invention belongs to the field of medicinal chemistry, and particularly relates to an isoxazole FXR receptor agonist and a preparation method and medical application thereof. The invention relates to a compound as shown in a formula (I), and pharmaceutically acceptable salts and isotope markers thereof. The compound as shown in the formula (I), the pharmaceutically acceptable salts and the isotope markers thereof have FXR receptor agonist activity and can be applied to preparation of drugs for treating or preventing hyperlipidemia, atherosclerosis, non-alcoholic steatohepatitis and type II diabetes mellitus.

Isoxazole derivative, pharmaceutical composition containing isoxazole derivative, and preparation method and application thereof

-

, (2021/05/19)

The present invention belongs to the field of pharmaceutical chemistry, and generally relates to an isoxazole derivative, and stereoisomers, tautomers, polymorphs, solvates (such as hydrates), esters, metabolites, N-oxides and chemically protected forms and prodrugs thereof, or pharmaceutically acceptable salts thereof. The invention also relates to a preparation method of the compound, a pharmaceutical composition containing the compound and application of the compound and the pharmaceutical composition in treating diseases or conditions mediated by farnesoid X receptor (FXR).

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 1103500-32-8